Clinical Trial Update: A Study to Evaluate the Efficacy and Safty of 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of a drug candidate labeled '608' in patients with non-radiographic axial spondyloarthritis; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis Non-radiographic

Drugs mentioned

• 608

Snippet

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Conditions: Axial Spondyloarthritis, Non-Radiographic | Phase 3 | Status: NOT_YET_RECRUITING